Importer of Controlled Substances Registration, 23581-23582 [2019-10669]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 99 / Wednesday, May 22, 2019 / Notices
87104. Or email comments to:
JOMcomments@bie.edu.
jbell on DSK3GLQ082PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Angela Barnett, Program Specialist,
Bureau of Indian Education; telephone
(405) 605–6051 ext. 302; email
ANGELA.BARNETT1@bie.edu.
SUPPLEMENTARY INFORMATION: The JOM
Act of 1934 was enacted to subsidize
education, medical services, and other
social services provided to Indians
living within the borders of states and
territories. Today, JOM funding is used
to support programs designed to meet
the specialized and unique educational
and cultural needs of eligible Indian
students, including programs that
supplement existing school
programming operational supports.
The JOM Modernization Act, Public
Law 115–404, enacted December 31,
2018, directs the Secretary of the
Interior (Secretary) to conduct an
accurate and comprehensive student
count for the purposes of calculating
formula allocations for programs under
the JOM Act and for other purposes. The
JOM Modernization Act also requires
the Secretary to make an initial
determination of the number of eligible
Indian students served, or potentially
served, by each eligible entity. In
accordance with the JOM Modernization
Act, the BIE will use the most
applicable and accurate data (from the
fiscal year preceding the fiscal year for
which the initial determination is to be
made) from one of the following
sources:
1. Bureau of the Census;
2. National Center for Education
Statistics; or
3. Office of Indian Education of the
Department of Education.
The BIE would like feedback on
which of these three sources can
provide the most accurate data for use
in the preliminary report. To obtain this
feedback, BIE is announcing Tribal
consultation sessions and the
opportunity for eligible entities and
interested parties to provide input.
Eligible entities include existing JOM
contractors and potential JOM
contractors, including States, public
school districts, tribal organizations,
Indian corporations, and previously
private schools. Interested parties
include, but are not limited to, JOM
Indian Education Committee members,
Tribal organizations, employees of
public schools serving American Indian
students, urban Indian communities,
VerDate Sep<11>2014
17:29 May 21, 2019
Jkt 247001
Indian school boards, parents, and
student organizations.
BIE is also interested in determining
the interest of Tribes, State and local
educational agencies, and Alaska Native
organizations of entering into JOM
contracts.
BIE will conduct a telephonic
consultation session and will accept
both oral and written comments. The
first hour of the session is reserved for
Tribal leaders and their representatives
to provide input. The rest of the time is
open to eligible parties and any other
interested parties who would like to
provide input, as follows:
June 21, 2019.
1 p.m.–3 p.m. MDT.
Please visit & join the meeting space
from your computer, tablet, or
smartphone.
https://www.gotomeet.me/
valerietodacheene/jom-consultation-mlesky.
Call-in number: (312) 757–3121.
Passcode: 843–649–541.
You can find additional information
at the BIE JOM web page at: https://
www.bie.edu/JOM/. The BIE strongly
recommends that anyone planning to
attend a consultation session first
review the preliminary data located on
BIE’s web page, to best engage in
meaningful dialogue.
At the conclusion of the
consultations, BIE will publish the
preliminary report and announce its
availability in the Federal Register.
Following publication of the
preliminary report, BIE will again seek
feedback for consideration in preparing
the final report.
Dated: May 7, 2019.
Tara Sweeney,
Assistant Secretary—Indian Affairs.
[FR Doc. 2019–10718 Filed 5–21–19; 8:45 am]
BILLING CODE 4337–15–P
23581
Notice of information collection;
withdrawal.
ACTION:
The National Park Service is
withdrawing a notice requesting
comments published in the May 14,
2019 issue of the Federal Register
entitled ‘‘National Park Service
President’s Park National Christmas
Tree Music Program Application’’.
DATES: As of May 22, 2019 the
document published at 84 FR 21354 on
May 14, 2019, is withdrawn.
FOR FURTHER INFORMATION CONTACT:
Phadrea Ponds, Acting NPS Information
Collection Clearance Officer, 1201
Oakridge Drive, Fort Collins, CO 80525;
at 970–267–7231.
SUPPLEMENTARY INFORMATION: The
National Park Service wishes to inform
the public it is withdrawing a 60-day
public notice in the Federal Register
titled, ‘‘National Park Service
President’s Park National Christmas
Tree Music Program Application’’ (84
FR 21354) published on Wednesday,
May 14, 2019. This notice was
published in error and is being
withdrawn immediately for public
comment.
SUMMARY:
Phadrea Ponds,
Acting Information Collection Clearance
Officer, National Park Service.
[FR Doc. 2019–10697 Filed 5–21–19; 8:45 am]
BILLING CODE 4312–52–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
The registrants listed below
have applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
schedule I and schedule II controlled
substances.
SUMMARY:
DEPARTMENT OF THE INTERIOR
National Park Service
[NPS–NCR–WHHO–SSB–NPS0027381;
PPNCWHHOP0, PPMVSIE1Z.I00000 (199);
OMB Control Number 1024–0277]
Agency Information Collection
Activities; National Park Service
President’s Park National Christmas
Tree Music Program Application;
Withdrawal
AGENCY:
PO 00000
National Park Service, Interior.
Frm 00060
Fmt 4703
Sfmt 4703
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for a hearing were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\22MYN1.SGM
22MYN1
23582
Federal Register / Vol. 84, No. 99 / Wednesday, May 22, 2019 / Notices
Company
FR docket
Meridian Medical Technologies .......................................................................................................
Organic Standards Solutions International, LLC .............................................................................
SpecGx LLC ....................................................................................................................................
84 FR 7129 ...............
84 FR 13958 .............
84 FR 13954 .............
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I
and II controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated each of the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I and schedule II controlled
substances to the above listed
companies.
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on March
8, 2019, United States Pharmacopeial,
12601 Twinbrook Parkway, Rockville,
Maryland 20852–1717 applied to be
registered as an importer of the
following basic classes of controlled
substances:
Dated: May 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–10669 Filed 5–21–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: United States
Pharmacopeial Convention
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before June 21, 2019. Such persons
may also file a written request for a
hearing on the application on or before
June 21, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
DATES:
jbell on DSK3GLQ082PROD with NOTICES
Controlled substance
17:29 May 21, 2019
Jkt 247001
PO 00000
Frm 00061
Fmt 4703
March 1, 2019.
April 8, 2019.
April 8, 2019.
Drug code
Methamphetamine ...........................................................................................................................................................
Cathinone ........................................................................................................................................................................
Phenmetrazine .................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Methaqualone ..................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .............................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
4-Methoxyamphetamine ..................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Phenylacetone .................................................................................................................................................................
Alphaprodine ....................................................................................................................................................................
Anileridine ........................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Difenoxin ..........................................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Heroin ..............................................................................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
VerDate Sep<11>2014
Published
Sfmt 4703
E:\FR\FM\22MYN1.SGM
22MYN1
1105
1235
1631
1724
2125
2270
2315
2550
2565
7315
7395
7400
7411
7471
8333
8501
9010
9020
9041
9053
9120
9168
9170
9200
9210
9220
9230
9273
Schedule
II
I
II
II
II
II
II
II
I
I
I
I
I
II
II
II
II
II
II
I
II
I
II
I
II
II
II
II
]]>Agencies
[Federal Register Volume 84, Number 99 (Wednesday, May 22, 2019)]
[Notices]
[Pages 23581-23582]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10669]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as importers
of schedule I and schedule II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as importers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted and no
requests for a hearing were submitted for these notices.
[[Page 23582]]
----------------------------------------------------------------------------------------------------------------
Company FR docket Published
----------------------------------------------------------------------------------------------------------------
Meridian Medical Technologies................. 84 FR 7129..................... March 1, 2019.
Organic Standards Solutions International, LLC 84 FR 13958.................... April 8, 2019.
SpecGx LLC.................................... 84 FR 13954.................... April 8, 2019.
----------------------------------------------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrants
to import the applicable basic classes of schedule I and II controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated each of the
company's maintenance of effective controls against diversion by
inspecting and testing each company's physical security systems,
verifying each company's compliance with state and local laws, and
reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I and schedule II controlled substances to the
above listed companies.
Dated: May 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-10669 Filed 5-21-19; 8:45 am]
BILLING CODE 4410-09-P
